167 related articles for article (PubMed ID: 15751456)
1. Prevalence of illicit drug use among individuals with chronic pain in the Commonwealth of Kentucky: an evaluation of patterns and trends.
Manchikanti L; Fellows B; Damron KS; Pampati V; McManus CD
J Ky Med Assoc; 2005 Feb; 103(2):55-62. PubMed ID: 15751456
[TBL] [Abstract][Full Text] [Related]
2. Controlled substance abuse and illicit drug use in chronic pain patients: An evaluation of multiple variables.
Manchikanti L; Cash KA; Damron KS; Manchukonda R; Pampati V; McManus CD
Pain Physician; 2006 Jul; 9(3):215-25. PubMed ID: 16886030
[TBL] [Abstract][Full Text] [Related]
3. Does random urine drug testing reduce illicit drug use in chronic pain patients receiving opioids?
Manchikanti L; Manchukonda R; Pampati V; Damron KS; Brandon DE; Cash KA; McManus CD
Pain Physician; 2006 Apr; 9(2):123-9. PubMed ID: 16703972
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of abuse of prescription and illicit drugs in chronic pain patients receiving short-acting (hydrocodone) or long-acting (methadone) opioids.
Manchikanti L; Manchukonda R; Pampati V; Damron KS
Pain Physician; 2005 Jul; 8(3):257-61. PubMed ID: 16850081
[TBL] [Abstract][Full Text] [Related]
5. Does adherence monitoring reduce controlled substance abuse in chronic pain patients?
Manchikanti L; Manchukonda R; Damron KS; Brandon D; McManus CD; Cash K
Pain Physician; 2006 Jan; 9(1):57-60. PubMed ID: 16700282
[TBL] [Abstract][Full Text] [Related]
6. A comparative evaluation of illicit drug use in patients with or without controlled substance abuse in interventional pain management.
Manchikanti L; Damron KS; Beyer CD; Pampati V
Pain Physician; 2003 Jul; 6(3):281-5. PubMed ID: 16880872
[TBL] [Abstract][Full Text] [Related]
7. Do users of regularly prescribed opioids have higher rates of substance use problems than nonusers?
Edlund MJ; Sullivan M; Steffick D; Harris KM; Wells KB
Pain Med; 2007; 8(8):647-56. PubMed ID: 18028043
[TBL] [Abstract][Full Text] [Related]
8. Patterns of illicit drug use and opioid abuse in patients with chronic pain at initial evaluation: a prospective, observational study.
Manchikanti L; Damron KS; McManus CD; Barnhill RC
Pain Physician; 2004 Oct; 7(4):431-7. PubMed ID: 16858484
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of side effects of prolonged low or moderate dose opioid therapy with concomitant benzodiazepine and/or antidepressant therapy in chronic non-cancer pain.
Manchikanti L; Manchikanti KN; Pampati V; Cash KA
Pain Physician; 2009; 12(1):259-67. PubMed ID: 19165308
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of illicit drug use in patients without controlled substance abuse in interventional pain management.
Manchikanti L; Pampati V; Damron KS; Beyer CD; Barnhill RC
Pain Physician; 2003 Apr; 6(2):173-8. PubMed ID: 16883377
[TBL] [Abstract][Full Text] [Related]
11. Prospective evaluation of patients with increasing opiate needs: prescription opiate abuse and illicit drug use.
Manchikanti L; Damron KS; Pampati V; McManus CD
Pain Physician; 2004 Jul; 7(3):339-44. PubMed ID: 16858472
[TBL] [Abstract][Full Text] [Related]
12. A prospective evaluation of psychotherapeutic and illicit drug use in patients presenting with chronic pain at the time of initial evaluation.
Manchikanti L; Cash KA; Malla Y; Pampati V; Fellows B
Pain Physician; 2013 Jan; 16(1):E1-E13. PubMed ID: 23340539
[TBL] [Abstract][Full Text] [Related]
13. National drug control policy and prescription drug abuse: facts and fallacies.
Manchikanti L
Pain Physician; 2007 May; 10(3):399-424. PubMed ID: 17525776
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of variables in illicit drug use: does a controlled substance abuse screening tool identify illicit drug use?
Manchikanti L; Pampati V; Damron KS; McManus CD
Pain Physician; 2004 Jan; 7(1):71-5. PubMed ID: 16868615
[TBL] [Abstract][Full Text] [Related]
15. Opioid analgesics and heroin: Examining drug misuse trends among a sample of drug treatment clients in Kentucky.
Victor GA; Walker R; Cole J; Logan TK
Int J Drug Policy; 2017 Aug; 46():1-6. PubMed ID: 28511053
[TBL] [Abstract][Full Text] [Related]
16. Strategies to optimize pain management with opioids while minimizing risk of abuse.
Brennan MJ; Stanos S
PM R; 2010 Jun; 2(6):544-58. PubMed ID: 20630441
[TBL] [Abstract][Full Text] [Related]
17. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic opioids: a ten-year perspective on the complexities and complications of the escalating use, abuse, and nonmedical use of opioids.
Manchikanti L; Singh A
Pain Physician; 2008 Mar; 11(2 Suppl):S63-88. PubMed ID: 18443641
[TBL] [Abstract][Full Text] [Related]
19. Gender and non-medical use of prescription opioids: results from a national US survey.
Tetrault JM; Desai RA; Becker WC; Fiellin DA; Concato J; Sullivan LE
Addiction; 2008 Feb; 103(2):258-68. PubMed ID: 18042194
[TBL] [Abstract][Full Text] [Related]
20. National All Schedules Prescription Electronic Reporting Act (NASPER): balancing substance abuse and medical necessity.
Manchikanti L; Brown KR; Singh V
Pain Physician; 2002 Jul; 5(3):294-319. PubMed ID: 16902657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
